These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 8880912

  • 1. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ, Kojima Y, Hackeng TM, Griffin JH.
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ, Yegneswaran S, Xu X, Pellequer JL, Griffin JH.
    J Biol Chem; 2007 Jul 27; 282(30):21848-55. PubMed ID: 17553804
    [Abstract] [Full Text] [Related]

  • 3. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
    Heeb MJ, Mesters RM, Fernández JA, Hackeng TM, Nakasone RK, Griffin JH.
    Thromb Haemost; 2013 Aug 27; 110(2):275-82. PubMed ID: 23892573
    [Abstract] [Full Text] [Related]

  • 4. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ, Rehemtulla A, Moussalli M, Kojima Y, Kaufman RJ.
    Eur J Biochem; 1999 Feb 27; 260(1):64-75. PubMed ID: 10091585
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa.
    Mounier CM, Hackeng TM, Schaeffer F, Faure G, Bon C, Griffin JH.
    J Biol Chem; 1998 Sep 11; 273(37):23764-72. PubMed ID: 9726985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. C-terminal residues 621-635 of protein S are essential for binding to factor Va.
    Heeb MJ, Kojima Y, Rosing J, Tans G, Griffin JH.
    J Biol Chem; 1999 Dec 17; 274(51):36187-92. PubMed ID: 10593904
    [Abstract] [Full Text] [Related]

  • 17. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X, Song X, Mahmood DFD, Sim MMS, Bidarian SJ, Wood JP.
    Thromb Res; 2023 Oct 17; 230():84-93. PubMed ID: 37660436
    [Abstract] [Full Text] [Related]

  • 18. Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Norstrøm EA, Tran S, Steen M, Dahlbäck B.
    J Biol Chem; 2006 Oct 20; 281(42):31486-94. PubMed ID: 16935856
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
    Steen M, Villoutreix BO, Norstrøm EA, Yamazaki T, Dahlbäck B.
    J Biol Chem; 2002 Dec 20; 277(51):50022-9. PubMed ID: 12384508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.